Medical Cannabis: What Lessons Can Be Learned for the UK?

Article from Drug Science’s Head of Research – Dr Anne Schlag An Evaluation of Regulatory Regimes of Medical Cannabis: What Lessons Can Be Learned for the UK? Despite the legalization of medical cannabis in the UK in November 2018, patients still lack access to this medicine, with fewer than 10 NHS prescriptions having been written  …


Project Twenty21

Drug Science launched Europe’s first and biggest national medical cannabis registry, called Project Twenty21, on the 7th November 2019. Project TWENTY21 aims to enrol 20,000 patients by the end of 2021, creating the largest body of evidence for the effectiveness and tolerability of medical cannabis – with an aim to demonstrate to policymakers that medical  …


Statement on the dangers posed by e-cigarettes

Drug Science stands by its e-cigarette analysis from 2014, any way of radically reducing the death toll from tobacco would be a worldwide public health triumph. e-cigarettes are not the solution to end the ever-increasing death toll caused by tobacco. However, they have proven to be an incredibly effective tool for tens of thousands of  …